Topics

A polymer nanogel crossed into the brain, lowered one protein in support cells, and produced working neurons plus better memory in mice.

InnoCare's TYK2 inhibitor soficitinib hits vitiligo Phase 2 endpoint, advancing to Phase 3. Competitive autoimmune skin disorder trial shows strong F-VASI improvement.

AI-driven drug discovery is transforming biotechnology as Big Tech acquires biotech startups, redefining pharmaceutical innovation and the future of AI-powered healthcare.

A custom treatment built from each patient's tumor mutations, given with an existing immunotherapy, met its main goals in a large late-stage study and relies on computational ranking of targets.

EPFL researchers activate three genes in memory neurons to reverse age-related decline and improve recall in models of Alzheimer's disease, offering new hope for brain health.

NUS Medicine, DayOne and Cortical Labs deploy 20 living-neuron CL1 units in a server rack cutting AI compute power to 30W per machine. "This is less power than a handheld-calculator".

UW–Madison researchers identify genes that block CRISPR success, offering a roadmap for safer gene therapy—particularly for inherited eye diseases.

Ambros and Ruvkun discovered microRNA, tiny RNA molecules that play a crucial role in gene regulation

Researchers in computational protein design and protein structure prediction assisted by AI have won the Nobel Prize in Chemistry.

Deo Fernaly discusses biotechnology's boundless horizons and explores the science, applications, and ethical dilemmas fueling a revolution in health, agriculture, and conservation.